James Trager
Director Técnico/Científico/I+D en NKARTA, INC. .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de James Trager
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NKARTA, INC. | Director Técnico/Científico/I+D | 01/09/2016 | - |
Historial de carrera de James Trager
Antiguos cargos conocidos de James Trager.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DENDREON CORPORATION | Director Técnico/Científico/I+D | 01/09/2003 | 01/12/2019 |
Formación de James Trager.
| St. John's College | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NKARTA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- James Trager
- Experiencia
